NSF International will be exhibiting at the leading UK pharmaceutical exhibition and conference, Making Pharmaceuticals, at the Ricoh Arena in Coventry, UK.
Taking place from 30 April to 1 May 2019, the exhibition features companies that are fundamental to every stage of the lifecycle of a pharmaceutical product, and the conference covers the major topics and issues facing the pharmaceutical industry.
Join NSF for a coffee and a chat with its team at stand 216. You will learn all about the company’s EDGE toolkit and pharma biotech services, including world-class regulatory and compliance consulting, auditing and training. You can also get involved in the company’s open discussion on what questions are key in your organisation, if you want to create long-term sustainable growth.
On 30 April, NSF International’s executive director of Pharma Biotech Pete Gough, who has 45 years’ experience in the industry and for the past 15 years has been responsible for advising senior management regarding changes to pharmaceutical legislation and guidance, will present the ‘The Impact of Brexit on Pharmaceuticals’ session at 14:50pm in room B. Pete’s presentation will focus on the current and future impact of Brexit on the supply of medicinal products in both the EU and UK.
Executive director of Pharma Biotech Lynne Byers will present the session ‘Managing Active Pharmaceutical Ingredient Supply Chains’ on the 1 May at 14:40pm in room B. Lynne will use the recent Valsartan recalls to examine how active pharmaceutical ingredient (API) supply chains should be managed. The presentation will use ICH Q9 principles to examine how companies and regulators use the standard. Lynne will also show how the regulatory framework supports regulators and marketing authorisation holders to assure API supply chains.
Register early at www.makingpharma.com to avoid the queues when you arrive. If you arrive before 10 a.m., you can enjoy breakfast on us! NSF look forward to seeing you. If you would like to schedule a meeting with our team, please get in touch using the contact form on this page.